Michael Levitz
CFO
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Anika Therapeutics, Inc. (ANIK) | Former EVP, Chief Financial Officer and Treasurer | $514,582 | $1,774,860 |
| 2023 | Anika Therapeutics, Inc. (ANIK) | Former EVP, Chief Financial Officer and Treasurer | $496,000 | $1,651,818 |
| 2022 | Anika Therapeutics, Inc. (ANIK) | Former EVP, Chief Financial Officer and Treasurer | $474,600 | $1,826,386 |
| 2021 | Anika Therapeutics, Inc. (ANIK) | EVP, Chief Financial Officer and Treasurer | $456,400 | $1,588,856 |
| 2020 | Anika Therapeutics, Inc. (ANIK) | EVP, Chief Financial Officer and Treasurer | $173,077 | $1,857,960 |
| 2019 | Anika Therapeutics, Inc. (ANIK) | EVP, Chief Financial Officer and Treasurer | — | — |
| 2018 | Anika Therapeutics, Inc. (ANIK) | EVP, Chief Financial Officer and Treasurer | — | — |
Executive changes
-
Resigned Executive Vice President, Chief Financial Officer and Treasurer at Anika Therapeutics, Inc. (ANIK)2024-05-02
Earnings-call appearances
-
Anika Therapeutics, Inc. Q1 FY2024 Earnings Call2024-05-08
Anika Therapeutics, Inc. (ANIK)
-
Anika Therapeutics, Inc. Q2 FY2023 Earnings Call2023-08-08
Anika Therapeutics, Inc. (ANIK)
-
Anika Therapeutics, Inc. Q1 FY2023 Earnings Call2023-05-09
Anika Therapeutics, Inc. (ANIK)
-
Anika Therapeutics, Inc. Q2 FY2022 Earnings Call2022-08-03
Anika Therapeutics, Inc. (ANIK)
-
Anika Therapeutics, Inc. Q1 FY2021 Earnings Call2021-05-06
Anika Therapeutics, Inc. (ANIK)
-
Anika Therapeutics, Inc. Q4 FY2020 Earnings Call2021-03-04
Anika Therapeutics, Inc. (ANIK)
-
Anika Therapeutics, Inc. Q3 FY2020 Earnings Call2020-11-04
Anika Therapeutics, Inc. (ANIK)